Rapid Micro Biosystems | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Rapid Micro Biosystems is a leader in automated detection of microbial contamination, primarily serving the pharmaceutical and biomanufacturing sectors. Headquartered in Lowell, Massachusetts, it also operates manufacturing facilities in the U.S. and maintains a presence in Switzerland, Germany, and the Netherlands. The organization is dedicated to enhancing microbial quality control processes through innovative automation and a strong commitment to data integrity.

The flagship Growth Direct® System is recognized as the first fully automated, growth-based platform for traditional microbial testing. It is engineered for key applications such as environmental monitoring, water testing, bioburden testing, and rapid sterility testing. The system accelerates contamination detection, improves data accuracy, reduces operational risks, and streamlines manufacturing timelines—making it an essential tool for the pharmaceutical, biotechnology, medical device, and personal care industries. Notably, it is especially suited to rigorously support cell and gene therapy quality control. A recent $81 million funding round reflects significant growth potential and a robust market position.